
Record High Strategies 10/24/25
Halftime Report
00:00
Merck and Healthcare Dividend Opportunities
Kevin discusses buying Merck for acquisition upside, dividend yield, and recovery as Keytruda patent concerns ease.
Transcript
Play full episode

Kevin discusses buying Merck for acquisition upside, dividend yield, and recovery as Keytruda patent concerns ease.